Your cart is empty
Peptagenix
Tirzepetide 20mg Pen
Tirzepetide 20mg Pen
Couldn't load pickup availability
This product is supplied in a pen form containing tirzepetide ingredients along with research information. Published literature about this product can be viewed in the resources section, and to purchase this peptide, you must sign a disclaimer to confirm the product purchase is not intended for human consumption.
Tirzepetide 20mg Pen Overview
Tirzepatide. 20mg
Peptirzepatide is a research version based on Tirzepatide.
Compound class: Peptide
Comment: Tirzepatide (LY3298176) is a clinical-stage dual GIP/GLP-1 agonist (‘incretin) that was developed to help manage type 2 diabetes mellitus (T2DM) [1,4] and as a novel anti-obesity medication. Structurally, a 39 amino acid linear peptide conjugated to a C20 fatty diacid moiety by a linker connected to the lysine20 residue. The dual agonist approach synergises the insulin and glucagonostatic responses compared to a GLP-1 agonist alone. It was the first dual-targeting single agent to be approved for T2DM management.
This product is sold solely for research purposes only, with written consent required before order fulfilment.
Share
